Microcoat now offering Assay Development and Sample Measurement on MSD® Platform
Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement. Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.
MORE NEWS
- 13Dez
Winner One-Line-Drawing PharmaLab 2024
Read More → - 27Nov
Microcoat Achieves ISO 14001:2015 Certification
Read More → - 01Okt
Microcoat announces the 11th Monocyte-Activation Test Proficiency Test Program
Read More → - 11Jul
Winner A3P Conference
Read More → - 17Jun
Microcoat announces the 10th Monocyte-Activation Test Proficiency Test Program
Read More → - 02Mai
Ausbildung
Read More → - 20Mrz
Meet us at Analytica 2024
Read More → - 08Jan
Low Endotoxin Recovery/Masking Training Course Munich/Bernried, GERMANY
Read More → - 25Sep
Meet us at PDA 2023
Read More → - 28Aug
Microcoat announces the 9th Monocyte-Activation Test Proficiency Test Program
Read More →